Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline PK/PD by CYP2D6/CYP2C19 in Healthy Korean Males
NCT02519400Phase 1Unknown
- Sponsor
- Asan Medical Center
- Start
- Aug 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
Phase 1, double-blind, single-arm trial of amitriptyline in major depressive disorder (MDD), sponsored by Asan Medical Center. Primary endpoints: Area under the plasma concentration-time curve at 96 hours and Maximum plasma concentration at 96 hours. Status: unknown.
02
Drugs
amitriptyline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02519400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519400.